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Human immunodeficiency virus type 1 (HIV-1) infection of the brain is associated with neurological manifestations both in
adults and in children. The primary target for HIV-1 infection in the brain is the microglia, but astrocytes can also be infected.
We tested 26 primary HIV-1 isolates for their capacity to infect human fetal astrocytes in culture. Eight of these isolates,
independent of their biological phenotype and chemokine receptor usage, were able to infect astrocytes. Although no
sustained viral replication could be demonstrated, the virus was recovered by coculture with receptive cells such as
macrophages or on stimulation with interleukin-1b. To gain knowledge into the molecular events that regulate attachment and
penetration of HIV-1 in astrocytes, we investigated the expression of several chemokine receptors. Fluorocytometry and
calcium-mobilization assay did not provide evidence of expression of any of the major HIV-1 coreceptors, including CXCR4,
CCR5, CCR3, and CCR2b, as well as the CD4 molecule on the cell surface of human fetal astrocytes. However, mRNA
transcripts for CXCR4, CCR5, Bonzo/STRL33/TYMSTR, and APJ were detected by RT-PCR. Furthermore, infection of
astrocytes by HIV-1 isolates with different chemokine receptor usage was not inhibited by the chemokines SDF-1b, RANTES,
MIP-1b, or MCP-1 or by antibodies directed against the third variable region or the CD4 binding site of gp120. These data
show that astrocytes can be infected by primary HIV-1 isolates via a mechanism independent of CD4 or major chemokine
receptors. Furthermore, astrocytes are potential carriers of latent HIV-1 and on activation may be implicated in spreading the
infection to other neighbouring cells, such as microglia or macrophages. © 1999 Academic PressKey Words: HIV-1; astrocytes; chemokine receptors; biological phenotype; latency.
e
s
a
d
C
1
t
i
e
w
C
1
b
t
r
t
d
i
w
jINTRODUCTION
Selected chemokine receptors serve as essential
embrane coreceptors of human immunodeficiency vi-
us type 1 (HIV-1), in combination with the CD4 molecule.
hese include CXCR4, the stromal cell-derived factor-1
SDF-1) receptor, which is used by T-cell-line-tropic HIV-1
trains, and CCR5, the RANTES (for regulated-upon-ac-
ivation, normal T cell expressed and secreted), macro-
hage inflammatory protein-1 (MIP-1) a and MIP-1b re-
eptor, which is used by non-T-cell-line-tropic strains
Berger, 1997). Additional chemokine receptors, such as
CR2b, CCR3, and CCR8, as well as some orphan re-
eptors (i.e., Bonzo/STRL33/TYMSTR, APJ, Bob/GPR15,
nd others) can be used by a limited number of viral
trains, albeit usually in combination with CXCR4, CCR5,
r both (Choe et al., 1996; Deng et al., 1997; Doranz et al.,
996; Edinger et al., 1998; Horuk et al., 1997; Loetscher et
l., 1997). The third variable region (V3) of the gp120
1 To whom reprint requests should be addressed. Fax: 39-022643-
w905. E-mail: scarlatti.gabriella@hsr.it.
042-6822/99 $30.00
opyright © 1999 by Academic Press
ll rights of reproduction in any form reserved.
370nvelope glycoprotein of HIV-1, a domain subjected to a
trong selective pressure in vivo, has been described as
critical determinant of the chemokine sensitivity of
ifferent viral isolates (Berger, 1997; Choe et al., 1996;
occhi et al., 1996; Oravecz et al., 1996; Paxton et al.,
996).
The distribution and function of chemokine receptors and
heir ligands within the brain are the objects of extensive
nvestigations. Microglial cells express CCR3, CCR5 (Vallat
t al., 1998; Xia et al., 1998), and CXCR4 (Lavi et al., 1997),
hereas neurons express the a-chemokine receptors
XCR4 (Lavi et al., 1997), CXCR2, and CXCR1 (Horuk et al.,
997). The distribution of APJ, an orphan seven-transmem-
rane domain receptor, in the brain is wide, and it is likely
o include neurons (Edinger et al., 1998). By contrast, the
esults of studies on the expression of chemokine recep-
ors on astrocytes are not always concordant. CXCR4 was
etected in rat (Jiang et al., 1998; Tanabe et al., 1997) but not
n human astrocytes (Sanders et al., 1998; Xia et al., 1998),
hereas CCR5 was identified in one study in healthy sub-
ects (Rottman et al., 1997) but in another only in patients
ith HIV encephalitis (Sanders et al., 1998).
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371HIV-1 INFECTION OF ASTROCYTESThe presence of HIV-1 in the brain has been demon-
trated on postmortem tissue from patients with ac-
uired immune deficiency syndrome (AIDS) using in situ
ybridization (Wiley et al., 1986) and immunohistochem-
cal techniques (Budka, 1990). The brain is a major site
or virus infection and replication (Shaw et al., 1985),
hich can occur at early stages of HIV-1 disease (Chiodi
t al., 1996). Astrocytes and microglial/macrophage cells,
ut apparently not neurons, were identified as the pri-
ary target for HIV-1 infection (Chiodi et al., 1996). One
hird of children with AIDS-associated leukoencephalitis
ave detectable HIV-1 in the brain, with a variable pro-
ortion of astrocytes infected (1–20%) (Saito et al., 1994;
ornatore et al., 1994). HIV-1-infected astrocytes have
een detected with electron microscopy and in situ PCR
n the brain of a number of adult patients with enceph-
lopathy (Epstein et al., 1984; Nuovo et al., 1994; Wiley et
l., 1986). However, the molecular mechanisms involved
n HIV-1 entry into astrocytes are still unknown. Indeed,
either CD4, the high-affinity viral receptor, nor galacto-
ylcerebroside, which was shown to function as an al-
ernative receptor on cultured brain cells (Harouse et al.,
991), can be detected on human fetal astrocytes (Ma et
l., 1994).
To gain knowledge into the molecular events that
egulate attachment and penetration of HIV-1 into astro-
ytes, we investigated the expression of chemokine re-
eptors by cell surface staining and mRNA analysis by
T-PCR. Moreover, we tested the susceptibility of astro-
ytes to primary HIV-1 isolates obtained from patients
ith different clinical characteristics, including central
ervous system dysfunction. We show that approxi-
ately one third of the viral isolates, independent of their
iological phenotype and chemokine receptor usage,
ere able to infect astrocytes in vitro. The lack of detec-
ion of CD4 and of the major HIV-1 coreceptors on the
ell surface of primary astrocytes supports alternative
echanisms of entry and implies that the use of chemo-
ine receptor-targeted therapeutic interventions will be
nefficient in preventing HIV-1 infection of astrocytes.
RESULTS
nfection of fetal astrocytes by primary HIV-1 isolates
Human fetal astrocytes were tested for their suscep-
ibility to infection by 26 well-characterized primary HIV-1
solates: 15 were obtained from 15 adults, and 11 were
btained from 9 children. The laboratory-adapted HIV-1IIIB
train was also tested. Among the primary HIV-1 isolates,
4 had the slow/low and 12 the rapid/high phenotype
Table 1). The purity of the astrocyte cultures was always
ssayed before infection, by staining with anti-glial fibril-
ary acidic protein (GFAP) antibodies (Fig. 1A); the ma-
ority of the cells (.95%) expressed this astrocyte-spe-
ific protein. Viral replication in primary astrocytes was
videnced by HIV-1 p24 antigen (HIV-1 Ag) detection in che supernatant collected during 30 days of follow-up of
he viral cultures only during the first days after infection
data not shown). However, HIV-1 infection of human
etal astrocytes was confirmed by PCR using two sets of
rimers that amplify the V3 region of the HIV-1 gp120 env
ene and the pol gene. The presence of HIV-1 DNA was
ocumented with both sets of primers for 8 of 26 (30.7%)
rimary viral isolates (A130, A136, V2, V7, B130-3, B136-3,
136-67, and B196-1) and for the HIV-1IIIB strain (Fig. 2).
he infection did not induce any cytophatic changes in
he cultures (Figs. 1B and 1C). No correlation was found
etween the biological phenotype of the viral isolates
nd their capability to infect human fetal astrocytes. Five
f the eight primary isolates that infected astrocytes
ere classified as slow/low; all these isolates were ca-
able of using only the chemokine receptor CCR5, as
ssessed by infection of U87.CD4 cells expressing dif-
erent chemokine receptors: CCR1, CCR2b, CCR3, CCR5,
nd CXCR4 (Table 1). The other 3 isolates were classified
s rapid/high: B196-1 was shown to use indifferently
XCR4, CCR5, or CCR3 as coreceptors, whereas V7 and
136-67 like HIV-1IIIB used only CXCR4.
Four of the viral isolates that infected astrocytes were
btained from adults (A130, A136, V2, V7), and four were
btained from children (B130-3, B136-3, B136-67, and
196-1). The ability to infect astrocytes was not higher
mong the viral isolates obtained from patients with
eurological symptoms, nor was there a correlation with
he clinical stage of the disease. Interestingly, seven of
he eight isolates capable of infecting primary astrocytes
ere obtained from three donor-recipient pairs: two
others and their respective children (A and B136, A and
130) and one heterosexual couple within 6 months from
resumed transmission (V2, the recipient and V7, the
ransmitter).
nalysis of the V3 loop sequences of HIV-1 isolates
The gp120 V3 region of the viral isolates capable of
nfecting primary astrocytes was sequenced. The amino-
cid sequence of the V3 loop was not predictive of
nfection of the astrocytes. Four (B130-3, B136-3, A130,
nd A136) were characterized by the presence of neutral
r negatively charged amino acids at positions 311 and
25 within the V3 loop (Myers et al., 1995) (Fig. 3). Two
solates (B196-1 and B136-67) had a positively charged
mino acid, arginine, at position 311. The other two viral
equences (V7 and V2) displayed a glycine at this posi-
ion and neutral or negatively charged amino acids at
osition 325 (data not shown). Although some substitu-
ions were observed in all the sequences, with respect to
IV-1 subtype B consensus, no specific substitution was
bserved, which could confer to these isolates the ability
o infect astrocytes. Moreover, no difference was seen by
omparison of the amino-acid sequence of the V3 region
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372 SABRI ET AL.f the viral isolates that infected astrocytes with that of
BMC infected with the homologous virus (Fig. 3).
ecovery and reactivation of HIV-1 expression
n astrocytes
To determine whether HIV-1 could be recovered from
nfected astrocytes, the cells were gently detached with
FIG. 1. (A) Human fetal brain cultures after selection for adherent c
overslips, fixed with acetone–methanol, and stained with monoclon
onjugated rabbit anti-mouse antibody and examined with the use of e
989). (B) Culture of astrocytes 5 days after infection with HIV-1. Examina
T
Clinical Stage of the Patients and Biological Charac
atient no.a
Clinical
stageb
CD41 cells
(cells/mm3)
dults
A 196 II 183
JF 1 II 191
JF 2 II 255
A 136 II 290
V9 II 382
JF 4 II 401
JF 6 II 416
V2 II 565
FC 15 IV A 20
FC 14 IV A 340
JF 7 IV C1 71
JF 8 IV C1 71
V7 IV C1 116
A 130 IV C1 280
V4 IV D 133
hildren
B 115-3 B1 1922
B 130-3 N1 3600
B 136-3 A1 3723
B 136-67 A3 412
B 145-1 A1 2386
B 193-4 B2 1087
B 196-1 A1 1825
B 204-0 N1 1930
B 204-1 A1 3216
B 225-1 N1 1580
B 256-1 N2 905
a The children’s labels are composed of the letter B, a progressive n
btained. The corresponding mother has the same number preceded
b CDC stage indicates the clinical and immunological status of the
ategories N, A, B, and C include children with no, mild, moderate, an
nd 3 include children with no, moderate, and severe immune suppre
c The absence of development of neurological symptoms is indicate
d The phenotype of the primary isolates is indicated as R/H for rapid
nd FC 15 were obtained from cerebrospinal fluid.
e Isolates were tested for their capacity to use the chemokine recept
D4 and the respective chemokine receptors. The use of the chemok
N.T., not tested.ormation. Magnification, 633. (C) Culture of astrocytes, not infected with HIV-1rypsin at day 7 after infection with 3 primary HIV-1
solates (B136-3, B136-67, and B196-1) representing all
ifferent types of tropism (R5 only, X4 only, and multi-
ropic X4R5/R3, respectively). After extensive washing,
he infected astrocytes were added to monocyte-derived
acrophages (MDM) cultures. HIV-1 Ag was first de-
ected after 10 days of coculture with all three virus
poly(D-lysine)-treated culture flasks. Cells were transferred to glass
ody to GFAP (DAKO). The detection of GFAP was made with FITC-
scence in a Zeiss ICM 405 inverted microscope (Major and Vacante,
cells by phase microscopy did not reveal cytopathic effects of syncytia
s of Their HIV-1 Isolates Used to Infect Astrocytes
elopment
urological
ptomsc
Viral isolate
phenotyped
Viral isolate
coreceptor usee
plasmosis R/H X4, R5, R3
No R/H n.t.
No S/L n.t.
No S/L R5
No S/L R5
No R/H n.t.
No R/H n.t.
No S/L R5
No S/L n.t.
No S/L n.t.
No R/H n.t.
plasmosis R/H n.t.
plasmosis R/H X4
No S/L R5
halopathy R/H X4, R5, R3
No S/L R5
No S/L R5
No S/L R5
No R/H X4
No S/L R5
halopathy S/L R5
halopathy R/H X4, R5, R3
No S/L R5
No R/H X4, R5, R3
No S/L R5
halopathy R/H, MT-2 neg R5
followed by the age, expressed in months, at which the sample was
letter A.
t a given age according to the 1994 CDC Classification for Children.
re signs or symptoms of HIV-1 infection, respectively. Categories 1, 2,
espectively.
“no.” Toxoplasmosis indicates cerebral involvement.
nd S/L for slow/low viral isolates. The viral isolates of patients FC 14
R4, CCR5, CCR3, CCR2b, and CCR1 in U87.MG cells transfected with
eptor is indicated with X4 for CXCR4, R5 for CCR5, and R3 for CCR3.ells on
al antib
pifluore
tion ofABLE 1
teristic
Dev
of ne
sym
Toxo
Toxo
Toxo
Encep
Encep
Encep
Encep
umber,
by the
child a
d seve
ssion, r
d with
high a
ors CXC
ine rec, which were sibling cultures to those shown in B. Magnification, 633.
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374 SABRI ET AL.solates, thus demonstrating that replication competent
irus could be rescued from latently infected fetal astro-
ytes (Fig. 4).
To determine whether latent HIV-1 infection of fetal
strocytes could be reactivated, the cells infected with
wo primary HIV-1 isolates (B136-3 and B196-1), and with
FIG. 2. Detection of HIV-1 DNA in human fetal astrocytes cultures by P
as a weight of 350 bp. Lane 1 shows the DNA marker PhiX174 DNA/H
rom astrocytes infected with HIV-1 isolates; and lane 11: DNA extract
FIG. 3. Alignment of the V3 region of the gp120 envelope glycoprote
ulture (A) is aligned to that from the PBMC culture (J) of each patient. Po
Myers et al., 1995). The asterisk (*) indicates position 311 of HIV-1MN. P
ndicated by assigning two or more amino acids at the same position on
equence. The total amino acid charge of the V3 loop was calculatedand E as negatively charged.IV-1IIIB were stimulated 6 days postinfection with the
nflammatory cytokines interleukin (IL)-1b, and tumor ne-
rosis factor (TNF)-a. The addition of IL-1b, but not of
NF-a, induced a transient release of virus for 3–4 days,
s detected by HIV-1 Ag in the supernatant of all three
nfected cultures 3 days after stimulation (Fig. 5).
e DNA fragment corresponding to the V3 region of the envelope gp120
ne 2, DNA extracted from uninfected cells; lanes 3–10, DNA extracted
ACH-2 cells, which contain one copy of proviral HIV-1 DNA/cell.
ences. The sequence of the viral isolate obtained from the astrocyte
of the first and last amino acids correspond to the sequence of HIV-1MN
at which the virus population displayed sequence polymorphism are
rneath the other. Dash denotes identity to the amino acid in the PBMC
ering amino acids H, K, and R as positively charged and amino acidsCR. Th
aeIII; la
ed fromin sequ
sitions
ositions
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375HIV-1 INFECTION OF ASTROCYTESxpression of chemokine receptors on astrocytes
To investigate the role of the chemokine receptors in the
ontrol of HIV-1 infection of primary astrocytes, we deter-
ined the expression of such molecules by different tech-
iques. By RT-PCR, transcripts were amplified for CXCR4,
CR5, Bonzo/STRL33/TYMSTR, and APJ but not for Bob/
PR15 (Fig. 6). However, no surface expression was de-
ected on the astrocytes by fluorocytometry using monoclo-
al antibodies against CXCR4, CXCR2, CXCR1, CCR5,
CR3, and CCR2 (Fig. 7, and data not shown). In addition,
either mRNA transcripts for CD4 nor staining by fluorocy-
ometry with antibodies to the CD4 molecule were demon-
trated (Figs. 6 and 7), whereas antibodies to ICAM-1 and
LA class-I, used as controls, showed a strong reactivity
FIG. 4. Recovery of virus from infected astrocytes by cocultiva
FIG. 5. IL-1b induces HIV-1 replication in infected human fetal as-
rocyte culture. HIV-1 p24 antigen production is indicated in pg/ml. The
ymbols indicate infections with isolates: E, B136-3; M, B196-1; and F,BIV-1IIIB.Fig. 7, and data not shown). Thus none of these chemokine
eceptors or the CD4 molecule was detected on the cell
urface of the human fetal astrocytes.
Chemokine receptors are G protein-coupled seven-
ransmembrane-domain receptors that mediate signal
ransduction and calcium mobilization when stimulated
ith the appropriate ligand. To further investigate the
xpression of chemokine receptors on the surface of
strocytes, we tested their response to different chemo-
ines, including RANTES, MIP1-a, MIP1-b, and MCP-1,
he natural ligands of the b-chemokine receptors CCR5,
CR3, CCR2b, and/or CCR1, as well as SDF-1b, the
igand of CXCR4, in a calcium mobilization assay. None
f these chemokines were able to induce a mobilization
f intracellular calcium in primary astrocytes, although it
id in control cells PM-1 and U87.CD4 transfected with
hemokine receptors (data not shown), further indicating
he absence of significant levels of such receptors on the
ell surface.
ack of inhibition of HIV-1 infection of astrocytes
y chemokines
To further exclude that infection of fetal astrocytes was
ediated by chemokine receptors expressed at very low
evels, we attempted to inhibit the entry of three viruses
B136-3, B136-67, and B196-1) with different coreceptor use,
sing the chemokines SDF-1b and RANTES, alone or in
ombination, as well as MIP-1b and MCP-1. None of these
hemokines inhibited HIV-1 infection of astrocytes, as de-
ermined by HIV-1 Ag ELISA (Fig. 8) and PCR (data not
hown) 2 and 3 days postinfection, regardless of the che-
okine receptor use of the viral isolate. A fourfold in-
reased dose of RANTES (1 mg/ml) alone or in combination
ith SDF-1b did not inhibit viral replication of isolates
th MDM. HIV-1 p24 antigen production is indicated in pg/ml.136-3 and B196-1 either (data not shown). These data
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376 SABRI ET AL.urther indicate that HIV-1 infection of primary astrocytes is
ndependent of the major chemokine receptors.
onoclonal antibodies against V3 and CD4-binding
ite do not block HIV-1 entry into astrocytes
We attempted to block viral infection of human fetal
FIG. 6. Human fetal astrocytes express CXCR4, CCR5, Bonzo/STRL
87.MG cells are included as controls. The amplification fragment has
YMSTR, 481 bp for APJ, 600 bp for Bob/GPR15, and 426 bp for CD4. T
mplification fragment of 661 bp. The marker is PhiX174 DNA/HaeIII.strocytes with two monoclonal antibodies: SIM4 di- bected toward the CD4-binding site and P4/D10 directed
gainst the tip of the V3 loop of the gp120 of HIV-1IIIB and
hown to have high cross-neutralizing capacity. Infection
y three primary isolates (B136-3, B136-67, and B196-1)
nd HIV-1IIIB could not be inhibited with these antibodies
t a concentration as high as 20 mg/ml, as determined by
STR, and APJ but not CD4 and Bob/GPR15 mRNA. MDM, PM-1 and
ght of 128 bp for CCR5, 682 bp for CXCR4, 750 bp for Bonzo/STRL33/
gene amplified with (RT1) and without (RT2) RT as a control has an33/TYM
a wei
he actinoth HIV-1 Ag detection (Fig. 8) and PCR (data not
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377HIV-1 INFECTION OF ASTROCYTEShown). However, both antibodies inhibited completely,
t 10-fold lower concentration, the replication of these
rimary isolates and HIV-1IIIB in PBMC cultures (data not
hown). Thus entry of primary HIV-1 isolates into astro-
ytes is apparently not mediated by the conventional
nvelope–receptor interactions occurring in CD41 cells.
hemokine production by astrocytes
The ability of astrocytes to produce SDF-1b and
FIG. 7. Human fetal astrocytes do not express chemokine receptors
nd CD4. Expression was assessed by indirect immunofluorescence
sing antibodies to CXCR4, CCR5, CCR3, CD4, and HLA class I and a
E-conjugated goat-antimouse IgG. The empty curves indicate the
sotype-matched control, whereas the full curves indicate results with
he different antibodies. U87.MG cells transfected with CD4 and the
ifferent chemokine receptors are shown as controls. The data are
epresentative of three different experiments.ANTES was investigated using semiquantitative RT- mCR or ELISA test. We were able to detect in human fetal
strocytes RNA transcripts of SDF-1b (.105 copy equiv-
lents/cell) by RT-PCR (data not shown); by contrast, no
ignificant levels of RANTES were found in the culture
upernatant, as assessed by ELISA with a commercial
it.
DISCUSSION
Our data show that human fetal astrocytes can be
nfected in vitro with primary HIV-1 isolates indepen-
ently of the biological phenotype and chemokine recep-
or use. Although viral replication was not sustained in
rimary fetal astrocytes, it was induced by stimulation
ith the cytokine IL-1b. These findings are in agreement
ith previous results obtained by infecting primary as-
rocyte cultures or astrocytic cell lines with laboratory-
dapted strains of HIV-1 (Cheng-Mayer et al., 1987;
hiodi et al., 1987; Tornatore et al., 1991). In those stud-
es, after an initial transitory release of viral antigen,
IV-1IIIB and NL4–3 were shown to establish a long-term
atent infection that could be activated by cytokines, as
L-1b and TNF-a. It is of interest to notice that these
ytokines can be produced by cells of the microglial/
acrophage lineage (Merril et al., 1992; Vitkovic et al.,
991), as well as by the astrocytes themselves (Chiodi et
l., 1996). However, IL-1b and TNF-a can also induce the
roduction of b-chemokines, such as RANTES, MCP-1,
nd MIP-1b, by human astrocytes (Barnes et al., 1996;
eterson et al., 1997), which could provide protection
rom infection by CCR5-dependent HIV-1 strains. Con-
omitant infections and inflammatory reactions at the
rain level might induce astrocytes to produce chemo-
ines, capable of attracting cells of the microglial/mac-
ophage lineage, which can in turn become infected by
he astrocytes. It can be envisaged that on proper stim-
lation astrocytes may enhance the expression of the
eceptors on their cell surface and thus be involved in
ell-to-cell cross-talk. Furthermore, we could recover vi-
us from infected astrocytes by cocultivation with MDM,
hus demonstrating that latently infected astrocytes may
ct as reservoir of HIV-1 and, when in contact with a
eceptive cell type, may easily spread the infection.
The mechanisms involved in HIV-1 entry into primary
strocytes are not yet characterized. In our study, we
how that viral infection of astrocytes is independent not
nly of CD4 but also of the major HIV-1 coreceptors
XCR4, CCR5, CCR3, and CCR2b. Indeed, none of the
igands of these receptors were able to inhibit or reduce
iral entry into primary astrocytes. Furthermore, although
ranscribed at the RNA level, none of these receptors
ppeared to be expressed on the cell surface, as as-
essed by fluorocytometry and mobilization of intracel-
ular free Ca21 in response to the appropriate chemo-
ines. Previous studies on the expression of a- or b-che-
okine receptors on astrocytes provided discordant
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378 SABRI ET AL.esults (Rottman et al., 1997; Sanders et al., 1998; Tanabe
t al., 1997). It is noteworthy that each study used differ-
nt technical approaches to purify astrocytes or to detect
he receptors. By immunocytochemistry, Sanders et al.
1998) detected expression of the chemokine receptors
XCR4 only in astrocytes of patients with HIV-1 enceph-
litis, not in controls. Analogously, a recent study showed
hat the b-chemokines MIP-1a, MIP-1b, and MCP-1 do
ot induce migration of primary fetal astrocytes (Peter-
on et al., 1997), suggesting the absence of their recep-
ors on the surface of primary human astrocytes. How-
ver, MIP-1b can induce migration of mouse astrocytes
Tanabe et al., 1997). Furthermore, it cannot be excluded
hat fetal and adult primary astrocytes may differ in che-
okine receptor expression.
Our data show for the first time that the orphan recep-
ors APJ and Bonzo/STRL33/TYMSTR are present as
RNA transcripts in human fetal astrocytes. Bonzo was
ever described to be present in the brain (Deng et al.,
997; Liao et al., 1997), whereas APJ was widely detected
n the brain and specifically in neurons (Matsumoto et al.,
996; O’Dowd et al., 1993). Thus expression of the latter
eceptor may be important for trafficking and cross-talk
f brain cells. APJ has been shown to be preferentially
sed by X4 or dual-tropic isolates but never in a CD4-
ndependent manner (Edinger et al., 1998). The lack of
pecific reagents, as well as of any known ligands for
uch molecules, has limited the characterization of their
ole in astrocyte infection.
The dichotomy that we observed between transcrip-
ion and expression on the cell surface of the chemokine
eceptors in astrocytes is puzzling. The absence of
XCR4 on the cell surface, despite mRNA transcription,
ay be explained by the production of specific cytokines
r chemokines by the astrocytes themselves. It is well
nown that astrocytes can produce IFN-g, which may in
urn down-regulate the expression of CXCR4 (De Simone
t al., 1998; Gupta et al., 1998; Nitta et al., 1994). Further-
ore, we showed mRNA transcription of SDF-1b in as-
FIG. 8. Inhibition of two primary isolates in astrocyte culture by a- a
inding site (SIM4). HIV-1 p24 antigen production is indicated in pg/mrocytes, which may have a similar effect (Amara et al., r997). On the contrary, astrocytes do not seem to pro-
uce RANTES (Barnes et al., 1996; Conant et al., 1998),
hich could help to explain the absence of CCR5 on the
ell surface. On the other hand, our findings may be
imply a consequence of the limit in sensitivity of meth-
ds like fluorocytometry or calcium mobilization com-
ared with the more-sensitive RT-PCR. This may also
elp to explain the discordant results of receptor detec-
ion in astrocytes described by different groups.
The lack of involvement of the major chemokine re-
eptors in HIV-1 infection of primary astrocytes is also
upported by our data showing that the V3 loop, which is
ritical for the coreceptor choice (Choe et al., 1996; Coc-
hi et al., 1996; Hwang et al., 1991; Rizzuto et al., 1998),
oes not seem to be involved in the uptake of the virus
y these cells. Monoclonal antibody P4/D10, shown to
eact with linear peptides representative of the tip of the
3 loop, including the Ile-X-X-Gly-Pro-Gly-Arg motif (Broli-
en et al., 1991), did not neutralize viral entry in primary
strocytes, although it neutralized the same viral isolates
n PBMC. In addition, monoclonal antibody SIM4, di-
ected toward the CD4-binding site of gp120, yielded
imilar results. Alternative mechanisms of HIV-1 entry
nto primary astrocytes were previously taken into con-
ideration. For example, galactosylcerebroside, de-
cribed to play a role in the uptake of HIV-1 by neural
ells (Ma et al., 1994), is not expressed on astrocytes.
IV-1 gp120 has been shown to interact with a protein of
olecular weight of 260 kDa present on the surface of
he astrocytes (Ma et al., 1994), but the role of this
nidentified protein as a receptor has not yet been dem-
nstrated.
Interestingly, most of the viral isolates that infected
strocytes were obtained from three donor-recipient
airs, two mothers and their children, and a heterosexual
ouple. This concordance in the capacity to infect astro-
ytes suggests that these viruses share common geno-
ypic determinants. However, the analysis of the V3 re-
ion of the gp120 gene of these viral isolates did not
hemokines and monoclonal antibodies anti-V3 (P4/D10) and anti-CD4nd b-ceveal any peculiarity that may underline the tropism for
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379HIV-1 INFECTION OF ASTROCYTESstrocytes. In previous reports, HIV-1 sequences with a
low/low genotype were found more often in infected
rain tissue than in the corresponding blood compart-
ent (Di Stefano et al., 1996; Korber et al., 1994). How-
ver, this phenomenon may be attributed to HIV-1 infec-
ion of other cells homing in the brain and expressing
revalently CCR5, like perivascular mononuclear cells or
icroglial cells (He et al., 1997; Vallat et al., 1998).
The biological phenotype of the viral isolates that can
nfect astrocytes appears to be unique among the iso-
ates tested, without a clearcut preference for slow/low
r rapid/high phenotype. Viruses with slow/low replica-
ive capacity are prevalent during the asymptomatic
hase of HIV-1 infection in adults (Åsjo¨ et al., 1986; Koot
t al., 1993) and children (Scarlatti et al., 1997); therefore,
n early infection of astrocytes might contribute to the
rain compartmentalization of HIV-1 infection. However,
apid/high viral isolates capable of using several b-che-
okine receptors in addition to CXCR4, as seen with our
solate B196-1, may be easily transmitted to other cells,
ike microglial cells, which support infection through
CR5 or CCR3 (He et al., 1997). None of these viral
solates was able to use Bob/GPR15 or Bonzo/STRL33/
YMSTR as coreceptors when tested in Ghost.CD4 cells
ransfected with the chemokine receptors (data not
hown).
Here we show that primary HIV-1 isolates can infect
ia a CD4/chemokine receptor-independent mechanism
uman fetal astrocytes in a latent fashion, although they
an readily be activated by inflammatory cytokines or
eceptive cells. The lack of detection of chemokine re-
eptors CXCR4, CCR5, CCR3, and CCR2 on the cell
urface of astrocytes indicates that infection of such
ells will not be affected by a- and b-chemokines, which
ave been described to inhibit HIV-1 replication (Bleul et
l., 1996; Cocchi et al., 1995; Oberlin et al., 1996). There-
ore, therapy with chemokine analogs will be inefficient
n astrocyte infection. It is easy to imagine the estab-
ishment of a self-perpetuating mechanism, in which
IV-1 infection per se induces cytokine production, and
n turn may activate latently infected astrocytes and
eighbouring cells. Thus astrocytes could become a
ossible reservoir for HIV-1 in the subcortical white mat-
er of the nervous system and a potential source of
nfection for infiltrating mononuclear cells or microglia of
he central nervous system.
MATERIALS AND METHODS
atients
Fifteen HIV-1-infected adults and nine infected chil-
ren born to HIV-1-infected mothers were selected from
larger cohort of patients from whom extensive fol-
ow-up with clinical and immunological staging was
vailable according to the classification systems of the
enters for Disease Control and Prevention (CDC) (Cen- sers for Disease Control, 1987, 1994). The development of
eurological symptoms during the progression of the
isease was recorded. The haematological and clinical
haracteristics of the HIV-1-infected patients are repre-
ented in Table 1. The children’s samples were obtained
etween birth and 4 months of age, except for child 136,
or whom we included also an isolate obtained at 67
onths. Four of the 15 adult patients had neurological
ymptoms: 1 presented with AIDS encephalopathy, 2 had
erebral toxoplasmosis at the time of sampling, and 1 (A
96) developed cerebral toxoplasmosis a few years later.
mong the pediatric patients, 3 developed encephalop-
thy by 2–3 years of age.
iral isolates, phenotype, and coreceptor use
haracterization
Twenty-six primary isolates of HIV-1 were obtained
rom patient peripheral blood mononuclear cells
PBMCs) or from cerebrospinal fluid (patients FC 14 and
5) by cocultivation with phytohemagglutinin (PHA)-stim-
lated PBMCs of healthy blood donors, as previously
escribed (Fenyo¨ et al., 1988). Seventeen of the HIV-1
rimary isolates were obtained from eight donor-recipi-
nt pairs: three mothers and their children and five het-
rosexual couples.
To characterize the viral phenotype PHA-stimulated
BMC (1 3 106) infected with each viral isolate were
ocultured with 3 3 106 cells of the various tumor cell
ines, including MT-2, HUT-78, C8166, Jurkat, Jurkat-Tat,
EM, and U-937, as previously described (Fenyo¨ et al.,
988). Virus isolates replicating in PBMCs and in Jurkat-
at, a highly permissive cell line to HIV-1 replication,
ere classified as slow/low; those replicating in two
dditional tumor cell lines as rapid/high.
Isolates were tested for their capacity to use the che-
okine receptors CXCR4, CCR5, CCR3, CCR2b, and
CR1 in U87.MG cells transfected with CD4 and the
espective chemokine receptors, as previously de-
cribed (Bjo¨rndal et al., 1997; Scarlatti et al., 1997).
reparation and infection of astrocyte cultures
Human fetal astrocytes were prepared as previously
escribed (Major and Vacante, 1989). Brain tissue was
btained from 9- to 14-week fetuses according to stan-
ards and guidelines established at the National Insti-
utes of Health. The tissue, dissected to remove menin-
es and blood vessels and mechanically disrupted
hrough a 19-gauge needle, was plated onto culture
lasks coated with poly(D-lysine) (0.1 mg/ml; Sigma). After
everal weeks, the cultures containing only a few neu-
onal phenotypes were placed in a rotary shaker at 250
pm for 3–4 h to detach the neuronal population. At-
ached cells, phenotypically astrocytes, were kept in cul-
ure and subjected to several additional rounds of rotary
haking. Only cultures with .95% GFAP-positive cells
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380 SABRI ET AL.ssessed by immunofluorescence (Eng et al., 1971) were
sed for infection experiments. These cultures also
ested negative for galactose ceramide, neurofilament,
c fragment, and RCA 1, indicating the absence of other
ells besides the astrocytes (Elder and Major, 1988). The
strocyte cultures were maintained and propagated in
agle’s minimum essential medium (E-MEM) supple-
ented with 10% FCS (Atlante Biologicals, Norcross,
A), glutamine, and antibiotics.
Approximately 2 3 106 human fetal astrocytes were
nfected with DNase-treated supernatant, shown by PCR
o avoid virus DNA carryover (results of the treated su-
ernatant not shown), of each viral isolate (1–2 ng/ml
IV-1 p24 antigen) in 25-cm2 flasks (Nunc). After an
vernight incubation at 37°C, the cells were washed
wice and further maintained for 30 days. Supernatants
ere collected every 3–4 days to test for the presence of
IV-1 Ag with an in-house assay (Scarlatti et al., 1997).
strocytes were collected 7 days postinfection to test for
he presence of HIV-1 genome by PCR. PBMC cultures
btained from healthy donors were infected in parallel to
he astrocyte cultures to ensure the infectivity of the viral
noculum. Viral replication in PBMCs could be detected
or all isolates (results not shown). The IIIB strain of
IV-1, previously shown to infect fetal astrocytes (Cheng-
ayer et al., 1987), was used as control in all experi-
ents.
nduction of active HIV-1 replication in latently
nfected astrocytes
Two different approaches were used to study the in-
uction of replication in latently infected astrocytes. At 6
ays postinfection, the astrocytes were washed and
hereafter cultured for 7 days with the addition of either
NF-a (10 ng/ml) or IL-1b (10 U/ml). Culture supernatants
ere collected daily for 1 week and tested for HIV-1 Ag
roduction with a sensitive commercial kit (Innogenetics,
wijndrecht, Belgium).
Furthermore, astrocytes after 7 days from infection
ere detached from the plastic by trypsin treatment,
xtensively washed, and then added to MDM obtained
y 7-day plastic adherence of PBMC in 6-well plates, as
reviously described (Valentin et al., 1991). Culture su-
ernatants were collected from the cocultures every 3–4
ays for 3 weeks and tested for HIV-1 Ag production with
n in-house assay.
nhibition of infection of astrocytes
SDF-1b (Upstate Biotechnology, NY), RANTES, MIP-1b,
nd monocyte chemotactic protein 1 (MCP-1) (R&D Sys-
ems, Minneapolis, MN), the natural ligands of the che-
okine receptors CXCR4, CCR5, CCR3, CCR2, and/or
CR1, as well as the monoclonal antibodies directed to
he CD4 binding site (SIM4) and to the V3 loop of gp120
P4/D10) (Åkerblom et al., 1990) were tested for the inhi- (ition of HIV-1 infection in fetal astrocytes. The chemo-
ines (SDF-1b at 1 mg/ml and the b-chemokines at 250
g/ml or 1 mg/ml) were added to 1 million astrocytes,
ultured in 6-well plates (Nunc), and incubated for 15 min
efore the addition of the DNase-treated supernatant (2
g/ml) of the viral isolates. The antibodies (P4/D10: 20
g/ml, or SIM4: 5 mg/ml) were incubated with viral su-
ernatants for 30 min before the addition to 1 million
strocytes. After an overnight incubation, the cells were
ashed six times and further incubated. Supernatant
as collected at days 2 and 3 postinfection for HIV-1 Ag
roduction with a commercial kit (Innogenetics). Cells,
ollected at day 3, were lysed to prepare DNA to assay
or the presence of viral genome by PCR. The sensitivity
o chemokines of the viral isolates used was previously
ssessed in PBMC and macrophage cultures (Scarlatti
t al., 1997). Cultures of PBMCs were used as control to
erify that infection could be blocked by the same anti-V3
onoclonal antibodies, as previously described (Broli-
en et al., 1990). In brief, viral supernatant was incubated
ith monoclonal antibody (at concentrations of 50, 10, 5,
, and 0.1 mg/ml) for 1 h at 37°C, and thereafter, PHA-
timulated PBMCs (50,000 cells/well) were added. Cul-
ure supernatants were assayed for the presence of
IV-1 Ag at day 7 postinfection.
NA and DNA preparation
Cellular RNA was extracted from astrocytes using
rizol (GIBCO) according to the manufacturer’s instruc-
ions and treated with 2 U of RNase-free DNase I to
emove contaminating DNA. First-strand cDNA synthesis
as obtained from 2 mg of RNA in 25 ml of mix containing
ligo(dT) primers, 200 U of Moloney murine leukemia
irus-RT (Promega), 25 nM concentration of each dNTP,
0 U of RNasin, 50 mM KCl, 10 mM Tris–HCl (pH 8.3), and
mM MgCl2. RNA was preheated at 65°C for 5 min and
ncubated with the reaction mix at 37°C. After a 1-h
ncubation, the reaction was stopped at 95°C for 5 min.
NA was obtained from 106 cells by extraction with a
henol–chloroform–isoamyl alcohol mixture and ethanol
recipitation. cDNA or DNA was used for PCR.
CR and sequencing of gp120–V3 region
HIV-1 was amplified from genomic DNA by PCR with
wo sets of nested primers including the V3 region of the
p120 gene and the pol gene, both of which detect one
opy of HIV-1 among 105 cells through most HIV-1 sub-
ypes (Alaeus et al., 1997; Brinchman et al., 1991; Scarlatti
t al., 1993). To sequence the V3 region, the PCR product
mplified with a set of biotinylated primers was directly
sed for solid-phase sequencing (Scarlatti et al., 1993).
riefly, DNA fragments obtained by amplification with
nner primers were purified by immobilization of the bio-
inylated primers on streptavidin-coated magnetic beads
Dynabeads M280-streptavidin; Dynal AS). The sequenc-
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381HIV-1 INFECTION OF ASTROCYTESng reaction was performed with fluorescein marked
rimers using a commercial kit (AutoRead; Pharmacia).
he sequence fragments were then loaded onto a 6%
olyacrylamide gel in an automated laser fluorescent
equencing apparatus (A.L.F.; Pharmacia LKB). Polymor-
hic nucleotide positions were indicated with IUPAC
odes to indicate that single virus variants differed in
mino acids at this position.
CR for CD4 and chemokine receptors CXCR4, CCR5,
onzo/STRL33/TYMSTR, APJ, and Bob/GPR15
Genomic DNA and cDNA were used as template for
CR. The CD4 sequence was amplified according to the
ethod previously described by Maddon et al. (1985).
he CCR5 sequence was amplified with the outer prim-
rs KR5fw.2 (59-ACATGCTGGTCATCCTCATCCTG-39) and
R5rv.2 (59-GTCCAACCTGTTAGAGCTACTGC-39) and the
nner primer pair KR5fw.3 (59-GTCTTCATTACACCTG-
AGCTCTC-39) and KR5rv.3 (59-GAGTAGCAGATGACCAT-
ACAAGC-39); the CXCR4 sequence with one set of
rimers FUSfw2 (59-GTTGATGCCGTGGCAAACTGG-39)
nd FUSrv2 (59-CTCTGCTCACAGAGGTGAGTG-39). Then
0 ml of DNA or 2.5 ml of cDNA were used for the outer
CR in a total volume of 100-ml reaction mixture contain-
ng 100 mM concentration of each dNTP (Pharmacia), 30
mol of each of the outer primers and 2.5 U of Taq DNA
olymerase (Perkin–Elmer Cetus, Norwalk, CT), 10 mM
ris–HCl, pH 8.3, 50 mM KCl, and 1.5 mM MgCl2.
For the CCR5 amplification with both set of primers,
enaturation at 94°C for 2 min was followed by 25 cycles
f 15 s at 95°C, 30 s at 55°C, and 30 s at 72°C each and
final extension at 65°C for 5 min. One microliter of the
irst-round PCR was amplified in a nested PCR in the
ame reaction mixture described above except for the
ddition of 30 pmol of the inner primers. The amplifica-
ion of CXCR4 was performed in the same reaction mix-
ure as for CCR5 inner primers but with 35 cycles of 30 s
t 94°C, 30 s at 54°C, and 30 s at 72°C each, followed by
n extension cycle at 72°C for 5 min.
Bonzo/STRL33/TYMSTR, APJ, and Bob/GPR15 were
mplified according to the previously described methods
Deng et al., 1997; Edinger et al., 1998).
The actin gene was amplified from cDNA after RT with
nd without the RT enzyme to confirm the absence of
enomic DNA (Act-fw: 59-TGACGGGGTCACCCACACT-
TGCCCATCTA-39; Act-rv: 59-CTAGAAGCATTGCGGTG-
ACGATGGAGGG-39). The PCR conditions were the
ame as for CXCR4, except for the annealing tempera-
ure of 65°C. The sensitivity of the PCR was 1 copy for
CR5, 100 copies for CXCR4, and 1000 copies for Bonzo/
TRL33/TYMSTR, APJ, and Bob/GPR.
Cells with known expression of the chemokine recep-
or genes and plasmids were included as positive and
egative controls. Amplified products (for CD4, 426 bp;
CR5, 128 bp; CXCR4, 682 bp; Bonzo/STRL33/TYMSTR, a50 bp; APJ, 481 bp; Bob/GPR15, 600 bp; and actin, 661
p) were separated on 4% agarose gel (NuSieve 3:1;
MC, Rockland, ME) and visualized by ethidium bromide
taining.
uantification of chemokines
cDNA was subjected to standard PCR amplification
sing primers specific for the SDF-1 coding region (SDF-
orward: 59-ACGAATTCGCGCCATGAACGCCAAGGTCGT-
9; SDF-backward: 59-CAGGATCCTGCAAACCCAGGC-
CGATC-39). The PCR conditions were as follows: dena-
uration at 95°C for 2 min, followed by 35 cycles of 95°C
or 30 s, 50°C for 30 s, and 72°C for 30 s. The amplifi-
ation products with a predicted size of 451 bp were
isualized by agarose gel electrophoresis and ethidium
romide staining. The sensitivity of the PCR was 100
opies. Levels of RANTES in the culture supernatant
ere tested with a commercial ELISA kit (R&D Systems),
ccording to the manufacturer’s indications.
ntracellular Ca21 measurements
Cells, detached from the plastic by gentle scraping,
ere washed extensively with a buffer (KRH) containing
final concentration of 125 mM NaCl, 5 mM KCl, 1.2 mM
gSO4, 1.2 mM KH2PO4, 25 mM HEPES/NaOH at pH 7.4,
mM CaCl2, and 6 mM glucose and resuspended at the
oncentration of 1 3 107/ml in the KRH buffer containing
iethylenetriaminepentaacetic acid (50 mM) and 3 mM
ura-2 AM (Sigma Chemical Co., St. Louis, MO) and
hereafter incubated for 45 min at room temperature in
he dark. For each determination, 2 3 106 cells were
entrifuged, and the supernatant was discarded and
esuspended in KRH buffer containing 250 mM sulfin-
yrazone. Cells were placed in a continuously stirring
uvette at 37°C in a dual-wavelength excitation source
luorometer (LS50B; Perkin–Elmer). Changes of cytosolic
ree calcium were determined after the addition of 100
M RANTES, MIP1-a, MIP1-b, MCP-1, and SDF-1b. Cal-
brations were determined with EGTA, Tris, Triton, and
a21. As control, receptive cells (PM-1 and U87.MG
ransfected with CD4 and the respective chemokine re-
eptors) were included, and astrocytes were stimulated
ith 1 mM of the calcium ionophore A23187.
mmunofluorescence
Cells (100,000/sample) were washed twice with PBS
GIBCO) and resuspended in 100 ml of PBS containing
% FCS (Sigma) and the respective monoclonal antibody.
ntibodies were directed to CXCR4 (12G5), CXCR2,
XCR1, CCR5 (2D7), CCR3 (7B11), CCR2, CD4, ICAM-1
Becton Dickinson), and HLA class-I (W6–32). After 30
in at 4°C, cells were washed twice and resuspended in
00 ml of PE-conjugated goat anti-mouse IgG (Southern
iotechnology Associates, Birmingham, AL). After 30 min
t 4°C, cells were extensively washed, fixed in 1.5%
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382 SABRI ET AL.araformaldehyde, and analyzed on the FACScan (Bec-
on Dickinson) to determine the level of surface expres-
ion. Cells with known expression of the chemokine
eceptors (U87.MG transfected with CD4 and chemokine
eceptors, PM-1, PHA-activated PBMCs, and MDM) were
ncluded as positive controls.
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